CN101780211B - Traditional Chinese medicine for treating infantile chronic cough and asthma - Google Patents
Traditional Chinese medicine for treating infantile chronic cough and asthma Download PDFInfo
- Publication number
- CN101780211B CN101780211B CN2010101307536A CN201010130753A CN101780211B CN 101780211 B CN101780211 B CN 101780211B CN 2010101307536 A CN2010101307536 A CN 2010101307536A CN 201010130753 A CN201010130753 A CN 201010130753A CN 101780211 B CN101780211 B CN 101780211B
- Authority
- CN
- China
- Prior art keywords
- asthma
- traditional chinese
- chinese medicine
- chronic cough
- treating infantile
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The present invention relates to a traditional Chinese medicine for treating infantile chronic cough and asthma, and belongs to the field of traditional Chinese medicines. The invention aims to adopt the traditional Chinese medicine theory to prepare the traditional Chinese medicine for treating infantile chronic cough and asthma, which can clear away lung-heat and detoxicate, eliminate phlegm and stop cough, purge lung and stop asthma. The active components of the invention comprise the following raw material by weight part: red tangerine peel, hogfennel root, ginkgo seed, pumice, baical skullcap root, apricot seed, bulbus fritilariae, liquorice root, heartleaf houttuynia herb, trichosanthes kirilowii maxim, perilla fruit, pinellia tuber and Poria. The invention has simple preparation, low cost, reliable curative effect, short time of treatment, no relapse, no toxic side effects like western medicines (antifungal agents), and good social and economic benefits, and is particularly important for some children which have allergic history for various antibiotics.
Description
Technical field:
The invention belongs to the field of Chinese medicines.
Background technology:
Infantile chronic cough and asthma is the clinical common frdquently encountered disease of department of pediatrics, and the disease of easy recurrence, brings great misery and worry for the infant and the head of a family.Also influence growth, the growth of infant.Comprise pediatric infantile acute bronchitis, bronchitis, children asthmatic brouchitis, children's bronchopneumonia, acute infantile pneumonia diseases such as (convalescent periods).The disease of infantile chronic cough and asthma accounts for first of the pediatric disease, physical weakness child at ordinary times particularly, and common morbidity repeatedly has a strong impact on children's's growth promoter and healthy living.Particularly the part children's all has allergies to various antibiotics, and is particularly important.
Summary of the invention:
The objective of the invention is to adopt theory of Chinese medical science, with clearing away lung-heat detoxifcation, preventing phlegm from forming and stopping coughing, the Chinese medicine of the treatment infantile chronic cough and asthma of eliminating the pathogens from the lung Dingchuan.
The present invention makes the raw materials of effective components weight portion and consists of:
The present invention makes raw materials of effective components optimum weight part and consists of:
The present invention prepares simply, and cheap, curative effect is reliable, and treatment time is short, should not recur, and does not more have the toxic and side effects that resembles Western medicine (bacteriums disappears).Social benefit is good, and economic benefit is splendid.Particularly the part children's all has allergies particularly important to various antibiotics.
The specific embodiment:
The present invention makes the raw materials of effective components weight portion and consists of:
The present invention makes raw materials of effective components optimum weight part and consists of:
Preparation method of the present invention:
At first, soaked 30 minutes, after the reuse big fire is boiled 30 minutes the above-mentioned medicinal cold water 1000ml that respectively distinguishes the flavor of, using slow fire (little fire) instead decocts, decoct medicinal herbs liquid is surplus to be 100ml, with health gauze (three layers) filtering liquid medicine, and then adopts said method to repeat once, to obtain herb liquid is placed on for twice in one glass, divide two parts, every part of 100ml, every day secondary, each 50ml, one after each meal.(heating back)
Embodiment 1:
Preparation method:
At first, soaked 30 minutes, after the reuse big fire is boiled 30 minutes the above-mentioned medicinal cold water 1000ml that respectively distinguishes the flavor of, use slow fire (little fire) instead and decoct, decoct medicinal herbs liquid is surplus to be 100ml, with health gauze (three layers) filtering liquid medicine, and then adopt said method to repeat once, will obtain herb liquid and mix.
Embodiment 2:
Preparation method is with embodiment 1.
Embodiment 3:
Preparation method is with embodiment 1:
Most preferred embodiment of the present invention is:
Preparation method is with embodiment 1.
Radix Peucedani is gone into lung meridian in the present invention's prescription, the energy lowering the adverse-rising QI to resolve phlegm, and wind and heat dispersing can increase the respiratory tract secretion, phlegm-dispelling functions is arranged, and action time is longer, simultaneously influenza virus is had inhibitory action, has antibiotic and antifungic action.The bitter temperature of Semen Armeniacae Amarum, sweet in the mouth is gone into lung and large intestine channel, and the merit (theory of Chinese medical science has the lung and the large intestine being interior-exteriorly related) of relieving cough and relieving asthma loosening bowel to relieve constipation is arranged.Cure mainly the cough with dyspnea dyspnea with rapid and short breath, accumulation and obstruction of sputum.Two medicine compatibilities more can increase the merit of eliminating phlegm to relieve asthma antitussive, and antibiotic effect is also arranged.Radix Scutellariae in the side is cold in nature, bitter in the mouth, and lung moistening, large intestine channel has heat clearing and damp drying, the effect of eliminating fire and detoxication, the Radix Scutellariae decoct has a wider antimicrobial spectrum external, and it all has inhibitory action to staphylococcus, streptococcus, bordetella pertussis, Diplococcus pneumoniae etc.Semen Ginkgo property in the side is flat, sweet in the mouth, and is bitter, puckery, has the merit of astringing lung QI for relieving asthma.The present invention contains multiple alkaloid, as fritimine etc., has antitussive, phlegm-dispelling functions, in addition bronchial smooth muscle is had the spasmolytic anti-asthmatic action.Herba Houttuyniae cold nature in the side, the flavor raw meat, return lung meridian, have heat-clearing and toxic substances removing, the merit of the pain evacuation of pus that disappears, the present invention contains houttuynine sodium bisulfite, volatilization wet goods, Herba Houttuyniae all has in various degree inhibitory action to the blue formula positive of multiple leather such as staphylococcus aureus, Diplococcus pneumoniae, influenza liver bacterium and knot bacillus and negative bacteria, can strengthen the leukocytes phagocytic ability, human body immunity improving power, and antiinflammatory, antitussive effect are arranged.The Radix Glycyrrhizae coordinating the actions of various ingredients in a prescription, full side is a heat-clearing and toxic substances removing, preventing phlegm from forming and stopping coughing, the merit of eliminating the pathogens from the lung Dingchuan.
Acute toxicity testing data of the present invention:
Finish by Changchun University of Traditional Chinese Medicine new drug center (or claiming State Administration of Traditional Chinese Medicine's Chinese medicine management three grades of laboratorys).
Purpose: observe the maximum dosage-feeding of heavy dose of administration of the present invention to gastric infusion in acute toxic reaction that animal produced and the 24h.
Experiment material:
Experimental animal: Kunming mouse, body weight 20~22g, male and female half and half are purchased the high-new medical animal experiment center in Changchun, the quality certification number: (Ji) SCXK2003-2004.
Be subjected to the reagent thing: medicine 100ml/ bag of the present invention, contain crude drug amount 1.15g/ml, provide by Pharmacy department of No.1 Hospital of Jilin Univ..With 8 times (800%), 4 times (400%) of medicine simmer down to stock solution of the present invention, 2 times (200%), concentrating the back Cmax is that stock solution 800% contains crude drug amount 9.2g.ml during experiment.
Experimental technique:
LD50 measures: press the relevant requirements of provisions for new drugs approval, the LD50 that medicine of the present invention has been carried out gastric infusion measures.
Trial test: get 12 of mices, be divided into 3 groups at random, behind every group of 4 fasting 16h, irritate the medicinal liquid concentrated solution 400ml/kg body weight that stomach is given medicinal liquid 800%, 400% of the present invention and 200% respectively, animals administer is after observed continuously 7 days, and animal subject there is no overt toxicity reaction and dead as a result.
Experimental result:
Observation shows that animals administer rear section moving animals obviously reduces, and active state recovers normal behind the 24h, and body weight is observed and shown that the weight of animals is not subjected to obviously to influence, and breathing, diet, drinking-water etc. are normal, mouth, eye, the no abnormal secretions of nose.Observation period does not have animal dead.Can prove that thus toxicity of the present invention is lower, oral safer.
Clinical data:
1, case is selected: infantile acute bronchitis, bronchitis, panting property arm inflammation, bronchopneumonia diagnostic criteria are with reference to " the pediatrics of being compiled by Xue Xin owner.
2, ordinary circumstance: outpatient service reaches and accepts 62 routine infants in hospital for medical treatment, is divided into two groups at random, treatment group (of the present invention group) 32 examples, male 17 examples, woman's 15 examples, 4.5~8 years old 8 age example, 9~14 years old 24 example, diagnosing acute bronchitis 12 examples, bronchitis 6 examples, asthmatic bronchitis 5 examples, bronchopneumonia 9 examples.Matched group (infantile lung heat cough with asthma oral liquid), 4~7.5 years old 7 example, 8~14 years old 23 example is diagnosed as acute bronchitis 14 examples, bronchitis 7 examples, asthmatic bronchitis 4 examples, bronchopneumonia 5 examples.Two groups of clinical bronchitis 4 examples of infant, bronchopneumonia 5 examples.Two groups of infant clinical data there was no significant differences (P>0.05) have comparability.
3, Therapeutic Method: the treatment group is at first made water decoction with the present invention, the 50ml/ bag/time, 2 times on the 1st, serve on 7 days.The oral infantile lung heat cough with asthma of matched group oral liquid (producing) by Heilungkiang sunflower pharmaceutcal corporation, Ltd.Authentication code: the accurate word z1095080 of traditional Chinese medicines, 10ml/1 props up, and 2 times on the 1st, two groups was a course of treatment with 7 days all.
4, observation index: after the treatment in 7 days of two groups of cases, observe its clinical cardinal symptom and sign, and sign extinction time and the comparison of disease cure rate aspect, treatment group as a result obviously is better than matched group.See table 1, table 2 for details.
Table 1 liang group symptom and sign again often between relatively
With matched group more 1. P<0.05,2. P<0.01.
Table 2 liang group curative effect of disease relatively
With matched group more 1. P<0.05,2. P<0.01.
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010101307536A CN101780211B (en) | 2010-03-24 | 2010-03-24 | Traditional Chinese medicine for treating infantile chronic cough and asthma |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010101307536A CN101780211B (en) | 2010-03-24 | 2010-03-24 | Traditional Chinese medicine for treating infantile chronic cough and asthma |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101780211A CN101780211A (en) | 2010-07-21 |
CN101780211B true CN101780211B (en) | 2011-10-26 |
Family
ID=42520435
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010101307536A Expired - Fee Related CN101780211B (en) | 2010-03-24 | 2010-03-24 | Traditional Chinese medicine for treating infantile chronic cough and asthma |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101780211B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103768571B (en) * | 2014-02-12 | 2016-02-03 | 李霞 | The Chinese medicine composition for the treatment of children chronic bronchitis and preparation method |
CN103845718B (en) * | 2014-03-19 | 2016-03-30 | 周玉娟 | A kind of medicine and preparation method for the treatment of cough and asthma |
CN105233057A (en) * | 2015-11-10 | 2016-01-13 | 叶建斌 | Traditional Chinese medicine oral liquid for treating cough and asthma of infant and preparing method thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101181556A (en) * | 2007-11-21 | 2008-05-21 | 胡公英 | Chinese medicine prescription orally taken for curing chronic bronchitis |
CN101411812A (en) * | 2008-11-25 | 2009-04-22 | 北京同仁堂股份有限公司 | Pharmaceutical formulation of Chinese white olive for relieving cough and preparation method thereof |
CN101607034A (en) * | 2008-06-22 | 2009-12-23 | 李军 | Method for treating middle-aged asthma by foot bath with traditional Chinese medicines |
-
2010
- 2010-03-24 CN CN2010101307536A patent/CN101780211B/en not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101181556A (en) * | 2007-11-21 | 2008-05-21 | 胡公英 | Chinese medicine prescription orally taken for curing chronic bronchitis |
CN101607034A (en) * | 2008-06-22 | 2009-12-23 | 李军 | Method for treating middle-aged asthma by foot bath with traditional Chinese medicines |
CN101411812A (en) * | 2008-11-25 | 2009-04-22 | 北京同仁堂股份有限公司 | Pharmaceutical formulation of Chinese white olive for relieving cough and preparation method thereof |
Non-Patent Citations (3)
Title |
---|
刘德泉.咳喘证用药规律浅探.《山东中医杂志》.1995,第14卷(第03期),100-101. * |
李光辉等.用宣、肃、温、润四法治疗小儿咳喘体会.《河南中医》.2008,第28卷(第03期),71-72. * |
李有田等.复方止咳灵治疗小儿咳喘32例疗效及急毒试验.《辽宁中医杂志》.2008,第35卷(第04期),561-562. * |
Also Published As
Publication number | Publication date |
---|---|
CN101780211A (en) | 2010-07-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101474385B (en) | Method for preparing Chinese medicine for treating children's summer-wet type common cold | |
CN104491342A (en) | Medicament for treating diabetes and preparation method thereof | |
CN101780211B (en) | Traditional Chinese medicine for treating infantile chronic cough and asthma | |
CN101259242B (en) | Medicine for treating allergic rhinitis | |
CN103127430A (en) | Medicament for treating lower respiratory tract infection and preparation method thereof | |
CN102370840B (en) | Chinese medicinal composition for treating halitosis and canker sore and preparation method thereof | |
CN104208473A (en) | Traditional Chinese medicine composition for treating wind-heat type cough and asthma and use thereof | |
CN103142733B (en) | Chinese medicine composition for treating upper respiratory infection | |
CN102784378B (en) | Traditional Chinese medicine preparation for treating sub-health | |
CN104306793A (en) | Chinese herba preparation for treating lobar pneumonia | |
CN104288477A (en) | Traditional Chinese medicine preparation curing infantile asthma | |
CN103919895B (en) | The Chinese medicinal liquor of a kind of the intestines and stomach coordinating, treatment constipation | |
CN103720850A (en) | Traditional Chinese medicinal composition for treating pharyngitis and preparation method | |
CN105343503B (en) | A kind of pharmaceutical composition that treating sphagitis and its application | |
CN103919988B (en) | A kind of the intestines and stomach coordinating, treatment constipation Chinese medicinal liquor | |
CN103127411A (en) | Traditional Chinese medicine used for treating urinary tract infection disease | |
CN102949509A (en) | Pure traditional Chinese medical health protection syrup for clearing lung heat and stopping cough and preparation method thereof | |
CN103690757B (en) | Traditional Chinese medicine composition for treating lung-spleen deficiency child bronchitis | |
CN103705826B (en) | A kind of applying Chinese medicine to the umbilicus agent for the treatment of children's acute gastritis | |
CN103536673B (en) | Topical powder with strong enhanced immunity for removing food retention, bringing down fever and relieving cough and asthma, and application thereof | |
CN105288202A (en) | Pharmaceutical composition for curing infantile cough | |
CN105362548A (en) | Traditional Chinese medicine for treating allergic asthma | |
CN104208474A (en) | Traditional Chinese medicine composition for treating acute urinary tract infection and application thereof | |
CN105362888A (en) | Medicine for treating allergic rhinitis | |
CN103623369A (en) | Chinese medicinal formula for treating amygdalitis and chronic pharyngitis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20111026 Termination date: 20120324 |